The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115024782 11502478 2 F 2016 20160906 20150914 20160915 PER US-ASTELLAS-2015US021419 ASTELLAS 68.46 YR M Y 0.00000 20160915 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115024782 11502478 1 PS XTANDI ENZALUTAMIDE 1 Oral U 1484205PC 203415 160 MG CAPSULE QD
115024782 11502478 2 SS XTANDI ENZALUTAMIDE 1 Oral U 203415 120 MG CAPSULE QD
115024782 11502478 3 SS XTANDI ENZALUTAMIDE 1 Oral 203415 160 MG CAPSULE QD
115024782 11502478 4 SS NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN
115024782 11502478 5 SS MS CONTIN MORPHINE SULFATE 1 Oral 0 30 MG TABLET BID
115024782 11502478 6 SS ZOLOFT SERTRALINE HYDROCHLORIDE 1 Unknown 25 MG, ONCE DAILY (0.5 OF A 50 MG TABLET) U 1543979PC 0 25 MG TABLET QD
115024782 11502478 7 C LOTREL AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE 1 Unknown 10/20 MG, ONCE DAILY U 0 FORMULATION UNKNOWN QD
115024782 11502478 8 C PROSCAR FINASTERIDE 1 Unknown U 0 5 MG FORMULATION UNKNOWN
115024782 11502478 9 C ACIPHEX RABEPRAZOLE SODIUM 1 Unknown U 0 20 MG FORMULATION UNKNOWN
115024782 11502478 10 C ASPIRIN. ASPIRIN 1 Unknown U 0 81 MG FORMULATION UNKNOWN
115024782 11502478 11 C MIRALAX POLYETHYLENE GLYCOL 3350 1 Unknown UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN
115024782 11502478 12 C STOOL SOFTENER DOCUSATE CALCIUM 1 Unknown UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN
115024782 11502478 13 C CALCIUM CALCIUM 1 Unknown UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115024782 11502478 1 Prostate cancer
115024782 11502478 2 Prostatic specific antigen
115024782 11502478 4 Pain
115024782 11502478 5 Pain
115024782 11502478 6 Product used for unknown indication
115024782 11502478 7 Blood pressure abnormal
115024782 11502478 8 Prostatic disorder
115024782 11502478 9 Abdominal discomfort
115024782 11502478 10 Product used for unknown indication
115024782 11502478 11 Product used for unknown indication
115024782 11502478 12 Product used for unknown indication
115024782 11502478 13 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
115024782 11502478 Arthralgia
115024782 11502478 Breast enlargement
115024782 11502478 Breast tenderness
115024782 11502478 Decreased appetite
115024782 11502478 Flatulence
115024782 11502478 Hypersensitivity
115024782 11502478 Hypersomnia
115024782 11502478 Increased bronchial secretion
115024782 11502478 Increased upper airway secretion
115024782 11502478 Musculoskeletal chest pain
115024782 11502478 Pain
115024782 11502478 Prostatic specific antigen increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115024782 11502478 1 20150416 0